David J. Gallacher

648 total citations
11 papers, 452 citations indexed

About

David J. Gallacher is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, David J. Gallacher has authored 11 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in David J. Gallacher's work include Cardiac electrophysiology and arrhythmias (8 papers), Ion channel regulation and function (3 papers) and Pluripotent Stem Cells Research (2 papers). David J. Gallacher is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), Ion channel regulation and function (3 papers) and Pluripotent Stem Cells Research (2 papers). David J. Gallacher collaborates with scholars based in Belgium, United States and United Kingdom. David J. Gallacher's co-authors include Hua Rong Lu, Rob Towart, Karel Van Ammel, Blanca Rodríguez, Alfonso Bueno‐Orovio, Oliver J. Britton, Eddy Vlaminckx, A. Van de Water, Mark Mercola and A. K. Savchenko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, European Journal of Pharmacology and Toxicological Sciences.

In The Last Decade

David J. Gallacher

11 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David J. Gallacher Belgium	8	313	266	106	44	26	11	452
Rob Towart Belgium	9	393 1.3×	360 1.4×	179 1.7×	61 1.4×	18 0.7×	13	572
An N. Hermans Belgium	9	502 1.6×	446 1.7×	126 1.2×	48 1.1×	49 1.9×	12	696
Kylie A. Beattie United Kingdom	10	399 1.3×	295 1.1×	83 0.8×	29 0.7×	58 2.2×	21	502
Jean‐Michel Guillon France	11	184 0.6×	157 0.6×	116 1.1×	64 1.5×	22 0.8×	18	371
Karel Van Ammel Belgium	13	593 1.9×	501 1.9×	151 1.4×	51 1.2×	42 1.6×	26	790
James Kramer United States	7	549 1.8×	491 1.8×	210 2.0×	49 1.1×	63 2.4×	13	741
Chieko Kasai Japan	7	255 0.8×	228 0.9×	204 1.9×	84 1.9×	19 0.7×	9	422
Chris Pollard United Kingdom	14	493 1.6×	389 1.5×	99 0.9×	32 0.7×	50 1.9×	21	638
Lucía Romero Spain	17	664 2.1×	393 1.5×	128 1.2×	29 0.7×	28 1.1×	59	791
Loriano Galeotti United States	13	657 2.1×	302 1.1×	142 1.3×	160 3.6×	23 0.9×	29	818

Countries citing papers authored by David J. Gallacher

Since Specialization

Citations

This map shows the geographic impact of David J. Gallacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Gallacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Gallacher more than expected).

Fields of papers citing papers by David J. Gallacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Gallacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Gallacher. The network helps show where David J. Gallacher may publish in the future.

Co-authorship network of co-authors of David J. Gallacher

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Gallacher. A scholar is included among the top collaborators of David J. Gallacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Gallacher. David J. Gallacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Ammel, Karel Van, Margino Steemans, Mohamed Kreir, et al.. (2023). Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Frontiers in Pharmacology. 14. 1229960–1229960. 8 indexed citations

Lu, Hua Rong, et al.. (2022). Identifying Acute Cardiac Hazard in Early Drug Discovery Using a Calcium Transient High-Throughput Assay in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Frontiers in Physiology. 13. 838435–838435. 3 indexed citations

Lu, Hua Rong, et al.. (2018). Is iCEB a universal proarrhythmic biomarker covering TdP to non-TdP arrhythmias? A comparison against existing biomarkers. Journal of Pharmacological and Toxicological Methods. 93. 120–120. 1 indexed citations

Ewart, Lorna, Mike Aylott, Mark Deurinck, et al.. (2014). The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative. Toxicological Sciences. 142(2). 427–435. 53 indexed citations

Hemmeryckx, Bianca, Melissa Swinnen, David J. Gallacher, Hua Rong Lu, & H.R. Lijnen. (2014). Effect of sitagliptin treatment on metabolism and cardiac function in genetic diabetic mice. European Journal of Pharmacology. 723. 175–180. 11 indexed citations

Britton, Oliver J., Alfonso Bueno‐Orovio, Karel Van Ammel, et al.. (2013). Experimentally calibrated population of models predicts and explains intersubject variability in cardiac cellular electrophysiology. Proceedings of the National Academy of Sciences. 110(23). E2098–105. 230 indexed citations

Hemmeryckx, Bianca, Marc Hoylaerts, David J. Gallacher, et al.. (2012). Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice?. European Journal of Pharmacology. 700(1-3). 23–31. 16 indexed citations

Cerignoli, Fabio, A. K. Savchenko, David J. Gallacher, et al.. (2012). High throughput measurement of Ca2+ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry. Journal of Pharmacological and Toxicological Methods. 66(3). 246–256. 82 indexed citations

Nagai, Nobuo, Marc Hoylaerts, David J. Gallacher, Hua Rong Lu, & H.R. Lijnen. (2008). Prothrombotic effect of Rofecoxib in a murine venous thrombosis model. Thrombosis Research. 122(5). 668–673. 6 indexed citations

10.

Lu, Hua Rong, Eddy Vlaminckx, A. Van de Water, & David J. Gallacher. (2006). Calmodulin Antagonist W‐7 Prevents Sparfloxacin‐Induced Early Afterdepolarizations (EADs) in Isolated Rabbit Purkinje Fibers: Importance of Beat‐to‐Beat Instability of the Repolarization. Journal of Cardiovascular Electrophysiology. 17(4). 415–422. 20 indexed citations

11.

Lu, Hua Rong, Eddy Vlaminckx, A. Van de Water, & David J. Gallacher. (2004). Both β-adrenergic receptor stimulation and cardiac tissue type have important roles in elucidating the functional effects of IKs channel blockers in vitro. Journal of Pharmacological and Toxicological Methods. 51(2). 81–90. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact